24278306|t|Effects of NR1H3 genetic variation on the expression of liver X receptor alpha and the progression of Alzheimer's disease.
24278306|a|Alzheimer's disease (AD) has been postulated to involve defects in the clearance of amyloid-beta (Abeta). Activation of liver X receptor alpha (LXRalpha) increases the expression of apolipoprotein E (ApoE) as well as cholesterol transporters ABCA1 and ABCG1, leading to augmented clearance of Abeta. We have previously shown that the C allele of rs7120118 in the NR1H3 gene encoding LXRalpha reduces the risk of AD. Here, we wanted to assess whether the rs7120118 variation affects the progression of AD and modulates the expression of NR1H3 and its downstream targets APOE, ABCA1 and ABCG1.We utilized tissue samples from the inferior temporal cortex of 87 subjects, which were subdivided according to Braak staging into mild, moderate and severe AD groups on the basis of AD-related neurofibrillary pathology. APOE epsilon4 allele increased soluble Abeta42 levels in the tissue samples in a dose-dependent manner, but did not affect the expression status of APOE. In contrast, the CC genotype of rs7120118 was underrepresented in the severe group, although this result did not reach statistical significance. Also, patients with the CC genotype of rs7120118 showed significantly decreased soluble Abeta42 levels as compared to the patients with TT genotype. Although the severity of AD did not affect NR1H3 expression, the mRNA levels of NR1H3 among the patients with CT genotype of rs7120118 were significantly increased as compared to the patients with TT genotype. These results suggest that genetic variation in NR1H3 modulates the expression of LXRalpha and the levels of soluble Abeta42. 
24278306	11	16	NR1H3	Gene	10062
24278306	102	121	Alzheimer's disease	Disease	MESH:D000544
24278306	123	142	Alzheimer's disease	Disease	MESH:D000544
24278306	144	146	AD	Disease	MESH:D000544
24278306	207	219	amyloid-beta	Gene	351
24278306	221	226	Abeta	Gene	351
24278306	267	275	LXRalpha	Gene	10062
24278306	305	321	apolipoprotein E	Gene	348
24278306	323	327	ApoE	Gene	348
24278306	340	351	cholesterol	Chemical	MESH:D002784
24278306	365	370	ABCA1	Gene	19
24278306	375	380	ABCG1	Gene	9619
24278306	416	421	Abeta	Gene	351
24278306	469	478	rs7120118	SNP	tmVar:rs7120118;VariantGroup:0;CorrespondingGene:10062;RS#:7120118;CorrespondingSpecies:9606
24278306	486	491	NR1H3	Gene	10062
24278306	506	514	LXRalpha	Gene	10062
24278306	535	537	AD	Disease	MESH:D000544
24278306	577	586	rs7120118	SNP	tmVar:rs7120118;VariantGroup:0;CorrespondingGene:10062;RS#:7120118;CorrespondingSpecies:9606
24278306	624	626	AD	Disease	MESH:D000544
24278306	659	664	NR1H3	Gene	10062
24278306	692	696	APOE	Gene	348
24278306	698	703	ABCA1	Gene	19
24278306	871	873	AD	Disease	MESH:D000544
24278306	897	899	AD	Disease	MESH:D000544
24278306	935	939	APOE	Gene	348
24278306	974	981	Abeta42	Gene	351
24278306	1083	1087	APOE	Gene	348
24278306	1121	1130	rs7120118	SNP	tmVar:rs7120118;VariantGroup:0;CorrespondingGene:10062;RS#:7120118;CorrespondingSpecies:9606
24278306	1240	1248	patients	Species	9606
24278306	1273	1282	rs7120118	SNP	tmVar:rs7120118;VariantGroup:0;CorrespondingGene:10062;RS#:7120118;CorrespondingSpecies:9606
24278306	1322	1329	Abeta42	Gene	351
24278306	1356	1364	patients	Species	9606
24278306	1408	1410	AD	Disease	MESH:D000544
24278306	1426	1431	NR1H3	Gene	10062
24278306	1463	1468	NR1H3	Gene	10062
24278306	1479	1487	patients	Species	9606
24278306	1508	1517	rs7120118	SNP	tmVar:rs7120118;VariantGroup:0;CorrespondingGene:10062;RS#:7120118;CorrespondingSpecies:9606
24278306	1566	1574	patients	Species	9606
24278306	1641	1646	NR1H3	Gene	10062
24278306	1675	1683	LXRalpha	Gene	10062
24278306	1710	1717	Abeta42	Gene	351
24278306	Negative_Correlation	MESH:D000544	RS#:7120118;CorrespondingGene:10062
24278306	Association	10062	9619
24278306	Association	MESH:D000544	351
24278306	Negative_Correlation	MESH:D000544	10062
24278306	Association	10062	19
24278306	Association	MESH:D002784	19
24278306	Association	10062	348
24278306	Association	10062	351
24278306	Association	MESH:D000544	10062

